Targeting Translation Termination Machinery With Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations

Nucleic Acid Therapeutics - United States
doi 10.1089/nat.2019.0779
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Design of Novel Aminoglycoside Derivatives With Enhanced Suppression of Diseases-Causing Nonsense Mutations

English

Specific Block of Androgen Receptor Activity by Antisense Oligonucleotides

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2003English

Immunogenicity for Antisense Oligonucleotides: A Risk-Based Assessment

Bioanalysis
PharmacologyAnalytical ChemistryMedical Laboratory TechnologyClinical BiochemistryMedicineToxicologyPharmaceutics
2019English

Characterization of Stereoisomerism of Antisense Oligonucleotides.

NIPPON KAGAKU KAISHI
1995English

Novel Antisense Oligonucleotides Targeting TGF-β Inhibit in Vivo Scarring and Improve Surgical Outcome

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2003English

New Insights Into the Interplay Between the Translation Machinery and Nonsense-Mediated mRNA Decay Factors

Biochemical Society Transactions
Biochemistry
2018English

Mechanisms of the Inhibition of Reverse Transcription by Antisense Oligonucleotides.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations

PLoS ONE
Multidisciplinary
2014English

Inhibition of Neurogenic Precursor Proliferation by Antisense Thyroid Hormone Receptor Oligonucleotides

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy